Shivrajsinh Rana
Shivrajsinh Rana @shivrajsinhrana ·
Replying to @shivrajsinhrana
💊 THE DRUGS THAT ARE FAILING Antibiotics now failing: 💥 → Ampicillin: 1 in 5 UTIs resistant 😱 → Carbapenems — last resort: failing → Colistin — very last resort: failing 😬 When last-resort drugs fail: there is NOTHING left. 💥 #Superbugs #AMR (6/24)
1
Shivrajsinh Rana
Shivrajsinh Rana @shivrajsinhrana ·
Replying to @shivrajsinhrana
🔬 WHAT IS ANTIMICROBIAL RESISTANCE? Bacteria evolve to RESIST drugs. 💥 A routine infection becomes: → Untreatable 😱 → Life-threatening 😬 → Unstoppable 💥 Infections that killed in 1850 are killing again in 2026. #Superbugs #AMR (3/24)
1
Shivrajsinh Rana
Shivrajsinh Rana @shivrajsinhrana ·
Replying to @shivrajsinhrana
📊 THE LANCET DATA — STAGGERING 39.1 MILLION deaths from drug-resistant infections 2025–2050. 💥 169 MILLION deaths ASSOCIATED with resistance same period. 😱 That's 3 deaths per minute. Every minute. For 25 years. 😬 #Superbugs #AMR (2/24)
1
1
Shivrajsinh Rana
Shivrajsinh Rana @shivrajsinhrana ·
🦠 SUPERBUGS: 3 DEATHS PER MINUTE Antibiotics are running out. 🧵 → 39M deaths forecast 2025–2050 😱 → 1 in 6 infections drug-resistant 💥 → No new antibiotic class since 1987 → We're losing medicine itself. 😬 #Superbugs #AMR (1o35Jz
1
2
State of Health
State of Health @stateofhealthio ·
🌡️ New research warns of a “creeping catastrophe” as climate change, poverty and antimicrobial resistance drive a global rise in malaria, dengue, TB and HIV—especially in fragile health systems hammered by extreme weather and underfunding. #ClimateHealth #InfectiousDiseases #AMRR
5
One Health Advances
One Health Advances @One_Health_Adv ·
📝🌟 Calling all scholars! 📚 ✨ Ready to share your groundbreaking research? Check out our submission guidelines for One Health Advances and take the first step towards publication. �link.springer.com/journal/44280/…jmqX3 #AMR #foodsafety #animaldiseases #zoonoses #environmentalhealth
One Health Advances Cover Image
One Health Advances

One Health Advances is a peer-reviewed, open access journal committed to publish high-quality research articles, comments, correspondence and reviews focusing ...

From link.springer.com
7
ISGlobal
ISGlobal @ISGLOBALorg ·
⚗️ The number of antimicrobial candidates in the pipelines of major pharmaceutical companies has dropped by 35% since 2021, and only 14% of the antibiotics currently in development are designed for children under five. Meanwhile, #AMR is already responsible for over 4 million deaths each year. Via @scidevnet | #Microbiology #GlobalHealth scidev.net/global/news/fe…
Few new antibiotics for children, report warns

Pipeline of antibiotics under development is shrinking putting children at risk amid global drug resistance crisis, report finds.

From scidev.net
2
160
Ducit Blue Foundation
Ducit Blue Foundation @DucitBlueFdn ·
KES 3.0 united young Nigerian professionals to tackle AMR. A standout question: “What disease is AMR?” - a reminder it’s a growing public health threat. Thanks to Dr. Ridwan Yahaya, panelists, and everyone who joined! #AMR #OneHealth #YouthInHealth
22
AMR Club FUNAAB
AMR Club FUNAAB @Amrclubfunaab ·
To mark World Tuberculosis Day, we visited the Lafenwa Abattoir in Abeokuta to engage with butchers on the critical role of Antimicrobial Resistance (AMR). Awareness is the first step in ensuring food safety and public health. 🩺�� #WorldTBDay #AMR #OneHealtrM
23
C-CAMP
C-CAMP @CCAMP_India ·
Congratulations to C-CAMP healthtech startup HaystackAnalytics on raising $5 million in a recent funding round! A winner of the CCAMP @SBI_Foundation #AMR Challenge, Haystack’s flagship platform, infexn®️-NGS, uses next-generation sequencing for pathogen detection across bacteria, fungi, and viruses, along with antibiotic resistance, in a single test. This helps clinicians identify infections that conventional diagnostics often miss, enabling targeted therapies for patients. Today, over 1,000 clinicians across 300+ hospitals nationwide rely on infexn®️-NGS. In the past 18 months, HaystackAnalytics has raised close to $15 million from leading investors, including Sun Pharma, Alkem Laboratories, Ashish Kacholia, and 1Crowd Read more: digitalhealthnews.com/healthtech-sta… @HaystackLab @Taslimarif @PrinSciAdvOff @DBTIndia @BIRAC_2012 @NITIAayog @MoHFW_INDIA @startupindia @GoI_MeitY @meitystartuphub @ICMRDELHI @CARB_X @BMGFIndia @FINDdx @ICARS_global @gardp_amr @AMRActionFund @ITBTGoK @Startup_Kar @Ktech_biotech @DHFWKA
Healthtech Startup HaystackAnalytics Raises $5 Mn to Scale Genomics-driven Diagnostics in India

Mumbai-based healthtech startup HaystackAnalytics has raised $5 million in a funding round to expand its genomics-based diagnostic solutions across India. With the new capital infusion, the startup...

From digitalhealthnews.com
2
179